Document Detail


The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial.
MedLine Citation:
PMID:  23531328     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Maternal deficiency of the omega-3 fatty acid, docosahexaenoic acid (DHA), has been associated with perinatal depression, but there is evidence that supplementation with eicosapentaenoic acid (EPA) may be more effective than DHA in treating depressive symptoms. This trial tested the relative effects of EPA- and DHA-rich fish oils on prevention of depressive symptoms among pregnant women at an increased risk of depression.
STUDY DESIGN: We enrolled 126 pregnant women at risk for depression (Edinburgh Postnatal Depression Scale score 9-19 or a history of depression) in early pregnancy and randomly assigned them to receive EPA-rich fish oil (1060 mg EPA plus 274 mg DHA), DHA-rich fish oil (900 mg DHA plus 180 mg EPA), or soy oil placebo. Subjects completed the Beck Depression Inventory (BDI) and Mini-International Neuropsychiatric Interview at enrollment, 26-28 weeks, 34-36 weeks, and at 6-8 weeks' postpartum. Serum fatty acids were analyzed at entry and at 34-36 weeks' gestation.
RESULTS: One hundred eighteen women completed the trial. There were no differences between groups in BDI scores or other depression endpoints at any of the 3 time points after supplementation. The EPA- and DHA-rich fish oil groups exhibited significantly increased postsupplementation concentrations of serum EPA and serum DHA respectively. Serum DHA- concentrations at 34-36 weeks were inversely related to BDI scores in late pregnancy.
CONCLUSION: EPA-rich fish oil and DHA-rich fish oil supplementation did not prevent depressive symptoms during pregnancy or postpartum.
Authors:
Ellen L Mozurkewich; Chelsea M Clinton; Julie L Chilimigras; Susan E Hamilton; Lucy J Allbaugh; Deborah R Berman; Sheila M Marcus; Vivian C Romero; Marjorie C Treadwell; Kristie L Keeton; Anjel M Vahratian; Ronald M Schrader; Jianwei Ren; Zora Djuric
Related Documents :
8097788 - Aerosolized pentamidine for primary prophylaxis of pneumocystis carinii pneumonia: a co...
24989988 - Adaptation and validation of the treatment burden questionnaire (tbq) in english using ...
21234448 - Experimental model of combined pain and depression status in rats.
21671418 - Effect of oral vitamin c supplementation on serum uric acid: a meta-analysis of randomi...
8097788 - Aerosolized pentamidine for primary prophylaxis of pneumocystis carinii pneumonia: a co...
20041818 - Omega-3 polyunsaturated fatty acids and depression: a review of the evidence.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  208     ISSN:  1097-6868     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-27     Completed Date:  2013-06-17     Revised Date:  2014-05-07    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  313.e1-9     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2013 Mosby, Inc. All rights reserved.
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00711971
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Depression / diagnosis,  prevention & control*
Docosahexaenoic Acids / therapeutic use*
Double-Blind Method
Eicosapentaenoic Acid / therapeutic use*
Fatty Acids, Omega-3 / therapeutic use
Female
Humans
Pregnancy
Pregnancy Complications / diagnosis,  prevention & control*
Grant Support
ID/Acronym/Agency:
8UL1TR000041/TR/NCATS NIH HHS; P30 CA046592/CA/NCI NIH HHS; R21 AT004166/AT/NCCAM NIH HHS; R21 AT004166-03S1/AT/NCCAM NIH HHS; UL1 TR000041/TR/NCATS NIH HHS
Chemical
Reg. No./Substance:
0/Fatty Acids, Omega-3; 25167-62-8/Docosahexaenoic Acids; AAN7QOV9EA/Eicosapentaenoic Acid
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is thrombin activation predictive of subsequent preterm delivery?
Next Document:  Developmental programming for allergy: a secondary analysis of the Mothers, Omega-3, and Mental Heal...